Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • R&D 100 Awards

ScinoPharm to Manufacture Newly Approved Antidepressant Drug

By Pharmaceutical Processing | February 8, 2011

ScinoPharm,
an active pharmaceutical ingredient (API) and contract research and
manufacturing (CRAM) service provider, will provide commercial manufacturing
service of vilazodone hydrochloride active pharmaceutical ingredient (API) for
Clinical Data, Inc.’s Viibryd™, a new drug entity recently approved by the FDA.
 

Viibryd
is a novel drug for the treatment of adults with major depressive disorder
(MDD). The drug’s dual mechanism of action and side effect profile
differentiates itself from other antidepressants. Use of Viibryd did not cause
significant weight gain or interference with sexual function as seen with some
rival drugs.

“ScinoPharm
is proud of the fruitful partnership with Clinical Data by being its sole API
supplier of vilazodone hydrochloride during Viibryd’s launch. Beginning from
process research through timely development and optimization of long and
complicated synthetic processes, we have established a win-win
partnership,” said Dr. Jo Shen, President and CEO of ScinoPharm.

In
relationship similar to the one with Clinical Data, ScinoPharm partners with
other leading pharmaceutical companies for custom contract services from
clinical materials to commercial.  So far the company has handled more
than 60 NCE projects, with 4 currently in phase III and 3 having already been
approved for launch.

ScinoPharm
is set to expand its CRAM services through its new GMP plant in Changshu, China,
which is expected to be operational in Q3 2011. The Changshu plant will expand
the company’s overall R&D and production capabilities to capture the
business opportunities in the rapidly expanding Asian pharmaceutical market.

 

Related Articles Read More >

Astellas
Astellas to spend $70M on new biotech campus in South San Francisco
Rainin
Mettler Toledo Rainin expands facilities in Vacaville, California
Elemental Machines
Elemental Machines aims to enlist lab freezers in fight against climate change 
Pfizer logo
Pfizer seeks to comply with voluntary Net-Zero Standard by 2040

DeviceTalks Tuesdays

DeviceTalks Tuesdays

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.

Need Pharmaceutical Processing news in a minute?

We Deliver!
Pharmaceutical Processing Enewsletters get you caught up on all the mission critical news you need. Sign up today.
Enews Signup
Pharmaceutical Processing World
  • Subscribe to Our Free E-Newsletter
  • Contact Us
  • About Us
  • Advertise With Us
  • R&D World
  • Drug Delivery Business News
  • Drug Discovery & Development
  • DeviceTalks
  • MassDevice
  • Medical Design & Outsourcing
  • MEDICAL TUBING + EXTRUSION
  • Medical Design Sourcing
  • Medtech100 Index

Copyright © 2022 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • R&D 100 Awards